CEA and CA19-9 have also been reported to be useful for distinguishing bone metastasis caused by carcinoma from primary bone tumors or hematological malignancy, even though these tumor markers do not identify the primary site of the tumor [9, 10]. This evidence concerns the gene CEACAM5 and bone neoplasm.